Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 9733788)

Published in J Biol Chem on September 18, 1998

Authors

H Keilhack1, T Tenev, E Nyakatura, J Godovac-Zimmermann, L Nielsen, K Seedorf, F D Böhmer

Author Affiliations

1: Research Unit "Molecular Cell Biology," Medical Faculty, Friedrich Schiller University, D-07747 Jena, Germany.

Articles citing this

The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J (2000) 9.51

A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol (2005) 5.68

Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol (2010) 3.80

Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol (2005) 3.48

Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data. PLoS Comput Biol (2006) 1.74

Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells. Breast Cancer Res (2013) 1.67

Spatial organization of intracellular communication: insights from imaging. Nat Rev Mol Cell Biol (2010) 1.55

Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacol Ther (2008) 1.52

EGFR signaling in breast cancer: bad to the bone. Semin Cell Dev Biol (2010) 1.52

Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat Cell Biol (2011) 1.40

Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells. Mol Pharmacol (2008) 1.18

Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*. J Mol Signal (2008) 1.11

Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol Biosyst (2010) 1.11

Interactions of the NPXY microdomains of the low density lipoprotein receptor-related protein 1. Proteomics (2009) 1.07

Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity. J Biol Chem (2010) 1.07

Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells. J Biol Chem (2010) 1.05

Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. Endocrinology (2009) 1.03

Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1. J Cell Biol (2001) 0.99

Structural basis for activation of trimeric Gi proteins by multiple growth factor receptors via GIV/Girdin. Mol Biol Cell (2014) 0.98

Src homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. J Biol Chem (2011) 0.97

Ultraviolet irradiation-induces epidermal growth factor receptor (EGFR) nuclear translocation in human keratinocytes. J Cell Biochem (2009) 0.96

CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness. J Biol Chem (2013) 0.95

Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus. Nat Microbiol (2016) 0.91

Cross-talk between receptors with intrinsic tyrosine kinase activity and alpha1b-adrenoceptors. Biochem J (2000) 0.84

CB₁ cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells. Cell Signal (2013) 0.80

The tyrosine phosphatase SHP-1 negatively regulates cytotrophoblast proliferation in first-trimester human placenta by modulating EGFR activation. Cell Mol Life Sci (2012) 0.80

Effect of acute acid-base disturbances on ErbB1/2 tyrosine phosphorylation in rabbit renal proximal tubules. Am J Physiol Renal Physiol (2013) 0.80

Genetic Interactions of STAT3 and Anticancer Drug Development. Cancers (Basel) (2014) 0.79

SHP-1 arrests mouse early embryo development through downregulation of Nanog by dephosphorylation of STAT3. PLoS One (2014) 0.78

Molecular Mechanisms that Regulate Epidermal Growth Factor Receptor Inactivation. Clin Med Oncol (2008) 0.78

Retinoids arrest breast cancer cell proliferation: retinoic acid selectively reduces the duration of receptor tyrosine kinase signaling. Exp Cell Res (2004) 0.76

Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases. Int J Mol Sci (2015) 0.76

Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition. Cell Death Dis (2016) 0.76

Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res (2017) 0.75

Cell signaling as a cognitive process. EMBO J (2017) 0.75

Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). Oncotarget (2015) 0.75

Inhibition of Receptor Dimerization as a Novel Negative Feedback Mechanism of EGFR Signaling. PLoS One (2015) 0.75

c-Src/Cav1-dependent activation of the EGFR by Dsg2. Oncotarget (2016) 0.75

Articles by these authors

Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44

EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol (1994) 3.06

Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J (1987) 2.56

The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J (1987) 2.34

The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci (2000) 1.93

Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1995) 1.85

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest (1986) 1.84

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol (1987) 1.79

Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Trends Cell Biol (2001) 1.73

Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72

Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. EMBO J (1994) 1.68

Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res (1994) 1.63

Identification of Src phosphorylation sites in the catenin p120ctn. J Biol Chem (2001) 1.57

Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc Natl Acad Sci U S A (1998) 1.52

Is Congo red an amyloid-specific dye? J Biol Chem (2001) 1.48

Face memory impairments in patients with frontal lobe damage. Neurology (2001) 1.43

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect (2013) 1.34

Systematic in vivo RNAi analysis of putative components of the Drosophila cell death machinery. Cell Death Differ (2006) 1.30

The structural motif of beta-lactoglobulin and retinol-binding protein: a basic framework for binding and transport of small hydrophobic molecules? Trends Biochem Sci (1988) 1.26

An RNA model system for investigation of pseudouridine stabilization of the codon-anticodon interaction in tRNALys, tRNAHis and tRNATyr. J Biomol Struct Dyn (1998) 1.23

Arg-220 of the PstA protein is required for phosphate transport through the phosphate-specific transport system in Escherichia coli but not for alkaline phosphatase repression. J Bacteriol (1988) 1.21

Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C. J Biol Chem (1995) 1.20

Interleukin-1beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem (1998) 1.19

A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am J Epidemiol (1990) 1.18

Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Mol Cell Biol (1999) 1.18

PLD2 complexes with the EGF receptor and undergoes tyrosine phosphorylation at a single site upon agonist stimulation. J Biol Chem (1998) 1.18

Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. Cell Death Differ (2011) 1.18

Expression of the human papillomavirus type 18 E7 gene by a cassette-vector system for the transcription and translation of open reading frames in eukaryotic cells. EMBO J (1987) 1.17

Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction. J Biol Chem (1999) 1.16

Identification of human papillomavirus type 16 E7 protein by monoclonal antibodies. J Gen Virol (1987) 1.14

DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene (2006) 1.13

A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling. Circ Res (1999) 1.11

Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J Clin Invest (1996) 1.10

Binding of phosphatidic acid to the protein-tyrosine phosphatase SHP-1 as a basis for activity modulation. Biochemistry (1999) 1.10

Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells. Eur J Cell Biol (2000) 1.10

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res (1998) 1.10

Identification of an endothelial cell binding site on kininogen domain D3. J Biol Chem (1995) 1.09

Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296. Biochemistry (1997) 1.09

[Chronic fatigue syndrome--a controlled cross-sectional study]. Ugeskr Laeger (1994) 1.08

Terminal long tandem repeats in chromosomes form Chironomus pallidivittatus. Mol Cell Biol (1996) 1.08

Fear recognition deficits after focal brain damage: a cautionary note. Neurology (2000) 1.07

Redox regulation of signal transduction in mammalian cells. Biochem Pharmacol (2000) 1.06

Both SH2 domains are involved in interaction of SHP-1 with the epidermal growth factor receptor but cannot confer receptor-directed activity to SHP-1/SHP-2 chimera. J Biol Chem (1997) 1.05

Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor. Biochemistry (1999) 1.04

Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched non-tumor tissue. J Cancer Res Clin Oncol (2001) 1.04

Short-term reproducibility of computed tomography-based lung density measurements in alpha-1 antitrypsin deficiency and smokers with emphysema. Acta Radiol (2004) 1.04

Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp Cell Res (2003) 1.03

The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells. Oncogene (1999) 1.01

Comparative stereostructure-activity studies on GABAA and GABAB receptor sites and GABA uptake using rat brain membrane preparations. J Neurochem (1986) 1.01

Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation. Leukemia (2010) 0.99

Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1. J Cell Biol (2001) 0.99

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine. Eur J Biochem (1993) 0.99

Identification, synthesis and immunogenicity of cuticular collagens from the filarial nematodes Brugia malayi and Brugia pahangi. Mol Biochem Parasitol (1989) 0.94

The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor. J Immunol (1990) 0.92

The protein-tyrosine phosphatase SHP-1 binds to and dephosphorylates p120 catenin. J Biol Chem (2000) 0.92

Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem (2001) 0.91

Purification of a growth inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland. Exp Cell Res (1984) 0.91

Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem (1994) 0.90

Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling. Curr Med Chem (2000) 0.90

The maize major allergen, which is responsible for food-induced allergic reactions, is a lipid transfer protein. J Allergy Clin Immunol (2000) 0.89

Nutritional status of Danish rheumatoid arthritis patients and effects of a diet adjusted in energy intake, fish-meal, and antioxidants. Scand J Rheumatol (1996) 0.89

Posttranslational processing of human alpha 2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by hepatoma cells. Eur J Biochem (1994) 0.89

Serum sensitivity of a diversity of Escherichia coli antigenic reference strains. Correlation with an LPS variation phenomenon. APMIS (1990) 0.89

Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol (2007) 0.89

GABA receptors on the somatic muscle cells of the parasitic nematode, Ascaris suum: stereoselectivity indicates similarity to a GABAA-type agonist recognition site. Br J Pharmacol (1989) 0.89

Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s). Br J Cancer (1997) 0.88

Three-dimensional structure and subunit topology of the V(1) ATPase from Manduca sexta midgut. Biochemistry (2000) 0.88

Lights and shades on an historical vaccine canine distemper virus, the Rockborn strain. Vaccine (2010) 0.88

Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA. Eur J Clin Microbiol Infect Dis (2011) 0.87

A plasmodial alpha-tubulin cDNA from Physarum polycephalum. Nucleotide sequence and comparative analysis. J Mol Biol (1985) 0.87

Biochemical evidence for pathogenicity of rhodopsin kinase mutations correlated with the oguchi form of congenital stationary night blindness. Proc Natl Acad Sci U S A (1998) 0.87

PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction. Cell Tissue Res (2000) 0.86

Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells. Cancer Gene Ther (2001) 0.86

Studies on human porin. VIII. Expression of "Porin 31HL" channels in the plasmalemma of the acute-lymphoblastic-leukemia cell line KM3 as revealed by light- and electron-microscopy. Biol Chem Hoppe Seyler (1992) 0.86

Isolation and characterization of full and truncated forms of human breast carcinoma protein BA46 from human milk fat globule membranes. J Protein Chem (1998) 0.85

Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinoma. Urology (1989) 0.84

A genomic clone encoding a cryptophyte phycoerythrin alpha-subunit. Evidence for three alpha-subunits and an N-terminal membrane transit sequence. FEBS Lett (1990) 0.84

Analysis of Pan-European attitudes to the eradication and control of bovine viral diarrhoea. Vet Rec (2009) 0.84

Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade. Biochem J (2000) 0.84

Definition of signals for neuronal differentiation. Ann N Y Acad Sci (1995) 0.84

Expression and renaturation of the N-terminal extracellular domain of torpedo nicotinic acetylcholine receptor alpha-subunit. J Biol Chem (1998) 0.84

Major complications and deaths due to interventional ultrasonography: a review of 8000 cases. J Clin Ultrasound (1990) 0.84

Improvement of an in-gel tryptic digestion method for matrix-assisted laser desorption/ionization-time of flight mass spectrometry peptide mapping by use of volatile solubilizing agents. Proteomics (2001) 0.83

Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer? Evaluation of quantitative semi-automated sputum cytometry on radon- and uranium-exposed workers. Eur Respir J (2001) 0.83

Occlusal contacts in maximum intercuspation and craniomandibular dysfunction in 16- to 17-year-old adolescents. J Oral Rehabil (1991) 0.83

Post-translational modifications of endothelin receptor B from bovine lungs analyzed by mass spectrometry. J Biol Chem (1998) 0.83

The primary structure of monomeric beta-lactoglobulin I from horse colostrum (Equus caballus, Perissodactyla). Hoppe Seylers Z Physiol Chem (1984) 0.83

Correlations in palmitoylation and multiple phosphorylation of rat bradykinin B2 receptor in Chinese hamster ovary cells. J Biol Chem (1999) 0.83

Leukemia inhibitory factor production by rat mast cells. Eur J Immunol (1993) 0.82

Emulsion strategies in the microencapsulation of cells: pathways to thin coherent membranes. Biotechnol Bioeng (2005) 0.82

Comparison of six assays for glycosylated haemoglobin determination. Scand J Clin Lab Invest (1983) 0.82

Selective protein kinase inhibitors block head-specific differentiation in hydra. Cell Signal (2000) 0.81

Human proteome enhancement: high-recovery method and improved two-dimensional map of colostral fat globule membrane proteins. Electrophoresis (2001) 0.81

The amino acid sequence of Canada goose (Branta canadensis) and mute swan (Cygnus olor) hemoglobins. Two different species with identical beta-chains. Hoppe Seylers Z Physiol Chem (1982) 0.81

Nerve growth factor enhances antigen and other secretagogue-induced histamine release from rat peritoneal mast cells in the absence of phosphatidylserine. J Allergy Clin Immunol (1988) 0.81

Chronic fatigue syndrome--a controlled cross sectional study. J Rheumatol (1994) 0.81